drugset / Trial / NCT07285304
A Long-term Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis
NaSingle-groupOpen-labelTreatment
Summary
A clinical study to evaluate the long-term safety and efficacy of TS-172 in hyperphosphatemia patients on hemodialysis.
Timeline
- Start
- 2025-12-01
- Primary completion
- 2027-07-31
- Completion
- 2027-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TS-172 | Unknown | 20 mg | Oral |
| Subject | TS-172 | Unknown | 60 mg | Oral |